RPG
IBB icon

Risk Paradigm Group’s iShares Biotechnology ETF IBB Stock Holding History

Risk Paradigm Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,110
Closed -$439K – 145
2018
Q1 		$439K Buy
4,110
+324
+9% +$35.9K 0.56% 58
2017
Q4 		$404K Buy
3,786
+891
+31% +$95.2K 0.43% 68
2017
Q3 		$322K Buy
2,895
+45
+2% +$4.81K 0.39% 74
2017
Q2 		$295K Sell
2,850
-48
-2% -$4.73K 0.35% 78
2017
Q1 		$283K Buy
2,898
+210
+8% +$20.1K 0.32% 78
2016
Q4 		$238K Buy
+2,688
New +$245K 0.26% 84

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Risk Paradigm Group's IBB Position: Q2 2018 in Review

Risk Paradigm Group sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 4,110 shares — an estimated $439K sold.

Risk Paradigm Group first reported a position in IBB in Q4 2016 and held it in 6 quarters. The position peaked at $439K in Q1 2018. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • Risk Paradigm Group reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
  • Risk Paradigm Group sold 4,110 iShares Biotechnology ETF shares in Q2 2018, an estimated $439K.
  • Risk Paradigm Group first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 6 quarters.
  • Risk Paradigm Group's iShares Biotechnology ETF position peaked at $439K in Q1 2018.
  • 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.